ong-acting calcium channel blockers are being frequently used for the treatment of hypertension in clinical practice. In particular, amlodipine is one of the most prescribed drugs of long-acting calcium channel blockers. [1][2][3] According to the guidelines for the management of hypertension (JSH 2004), the combined treatment of long-acting calcium channel blockers and -blockers is recommended. 4 Betaxolol, a third generation -blocker, is characterized as being long-acting, 1-adrenoceptor selective antagonist with a mild vasodilator effect and has few effects on metabolism of carbohydrates and lipids. [5][6][7][8] It is assumed that calcium channel blockers and -blockers, could have synergistic effects on blood pressure (BP) decrease and prevent a reflex tachycardia caused by the calcium channel blockers.Heart rate variability (HRV) indexes are well known prognostic markers for the various cardiovascular disorders, including hypertensive patients. [9][10][11][12][13][14] It is likely that the combined treatment of calcium channel blockers and -blockers might have a beneficial effect on cardiac autonomic nervous activity (CANA) assessed by HRV. However, there are no studies to directly compare the dose-up effect of amlodipine with the adding effect of betaxolol on CANA in patients with low dose amlodipine therapy.Antihypertensive drug therapy might elicit adverse drug reactions and compromise the patient's health-related quality of life (HRQL). 15,16 Particularly, -blockers might be associated with symptoms such as fatigability and inactivity.Thus, the purpose of the present study was to evaluate whether betaxolol adding therapy could have better outcomes of CANA assessed by HRV and HRQL evaluated by the questionnaire sheets than amlodipine dose-up therapy in patients with a poor BP control with low dose amlodipine therapy.
Methods
Study PopulationThe study population consisted of 65 hypertensive patients (66±9 years, 36 men and 29 women) who were Circ J 2008; 72: 764 -769